Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults
Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults have?
Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults has 27 citations in the OpenAlex counts ScholarIQ stores.
When was Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults published?
Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults has 2018 year in the ScholarIQ index.
What is the open-access status of Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults?
Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults has closed oa status in the ScholarIQ index.
What is the DOI of Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults?
The DOI for Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults is on the source record.
What is the PMID of Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults?
The PMID for Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults is on the source record.
What is the OpenAlex record for Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults?
The OpenAlex for Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults is on the source record.